Fortis Group Advisors’s Cardinal Health CAH Stock Holding History

Fortis Group Advisors’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,693	Closed	-$794K	–	587
2025 Q4	$794K	Buy	+3,693	New	+$695K	0.13%	171

Other funds holding CAH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fortis Group Advisors's CAH Position: Q1 2026 in Review

Fortis Group Advisors sold out of Cardinal Health (CAH) in Q1 2026, closing a stake of 3,693 shares — an estimated $794K sold.

Fortis Group Advisors first reported a position in CAH in Q4 2025 and held it in 1 quarter. The position peaked at $794K in Q4 2025. 1,433 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

Fortis Group Advisors reported no remaining Cardinal Health position as of Q1 2026 after selling out during the quarter.
Fortis Group Advisors sold 3,693 Cardinal Health shares in Q1 2026, an estimated $794K.
Fortis Group Advisors first reported a position in Cardinal Health in Q4 2025 and held it in 1 quarter.
Fortis Group Advisors's Cardinal Health position peaked at $794K in Q4 2025.
1,433 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Fortis Group Advisors's 13F filing for Q1 2026, filed 8 May 2026.